🧬 Most new medicines are billion-dollar bets made in the dark.Charm Therapeutics is changing that — using AI to design drugs that actually work.Laksh Aithani, co-founder and CEO, joins the Founders and Builders podcast to break down how AI is transforming drug discovery — and why Charm raised $50M from Nvidia, General Catalyst, and Khosla Ventures to do it.We talk about:– The wild science behind protein folding– Why most drugs still fail in trials– How Charm slashes R&D timelines using DragonFold– What it really takes to build a biotech company at 27This episode is a window into the future of how medicine gets made.